Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT06195280

SUPerficial ENDometriosis In Magnetic Resonance Imaging

Prospective, Multicenter Study Evaluating the Diagnostic Performance of the 3DT1 Sequence in Magnetic Resonance Imaging for Superficial Endometriosis

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
GCS Ramsay Santé pour l'Enseignement et la Recherche · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of the study is to determine the correlation between the diagnosis of Superficial endometriosis by the 3DT1 sequence on Magnetic resonance imaging and the histology obtained by laparoscopy.

Detailed description

This is a prospective, multicenter, non-randomized study evaluating the diagnostic performance of Magnetic Resonance Imaging in superficial endometriosis. The duration of the patient's participation in the study is a maximum of 15 months depending on the length of the screening period and the time between Magnetic Resonance Imaging and laparoscopy. After selection, the investigator will check the patient's eligibility and offer her the study. If she accepts and signs the informed consent form, the patient will have an exploratory pelvic Magnetic Resonance Imaging lasting approximately 15 to 20 minutes, without systematic injection of contrast product. After Magnetic Resonance Imaging, the patient will benefit from a laparoscopy under general anesthesia lasting an average of one hour.

Conditions

Interventions

TypeNameDescription
RADIATIONMagnetic resonance imaging, 3DT1 sequenceThe patient will have an exploration pelvic Magnetic Resonance Imaging lasting approximately 15 to 20 minutes, without systematic injection of contrast product.
PROCEDURELaparoscopyAfter Magnetic Resonance Imaging, the patient will benefit from a laparoscopy under general anesthesia lasting an average of one hour.

Timeline

Start date
2025-04-01
Primary completion
2026-03-01
Completion
2026-03-01
First posted
2024-01-08
Last updated
2026-01-15

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06195280. Inclusion in this directory is not an endorsement.